Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports

DALLAS, September 28, 2010 - ReportsandReports announces it will carry Emerging Cancer Vaccines
Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Research
Report in its store.

Browse the complete Report on:
www.reportsandreports.com/reports/33665-emerging-cancer-vaccines-
forecasts-developments-and-pipeline-an.html

Search More Than 50000 Market Research Reports at ReportsandReports
(www.reportsandreports.com/)

Browse All Kalorama Information Research Reports at
www.reportsandreports.com/Publishers/kalorama-information

Kalorama has been researching and examining the development of cancer
vaccines for seven years. In April 2010, the cancer vaccine market
experienced one of the biggest achievements in the therapeutic vaccine
treatment of cancer-the approval of the prostate cancer vaccine PROVENGE
(TM). This, in addition to the success of cervical cancer vaccine products,
has created a viable market for what was merely a speculative area just one
decade ago.

Even with achievements for some companies, numerous vaccines with
apparently strong prospects have been hit by developmental delays and
failures. These include CancerVax's Canvaxin, Aphton's Insegia, Progenics'
GMK vaccine, and Biomira's Theratope. Despite setbacks many developers are
hopeful of a turnaround. With a couple prophylactic vaccines for cervical
cancer on the market, a few select therapeutic vaccine approvals and several
therapeutic vaccines on a promising path to commercialization, the market
could see a surge of regulatory activity and an influx of market
opportunities.

This Kalorama Information report - Emerging Cancer Vaccines: Forecasts,
Developments and Pipeline Analysis - focuses on both preventive and
therapeutic cancer vaccines in development. The following cancers for which
there are vaccines in development or where there is a potential are profiled:

    - Cervical
    - Colon/Rectal
    - Lung
    - Lymphoma
    - Melanoma
    - Prostate
    - Breast
    - Gastrointestinal
    - Renal
    - Brain
    - Bladder
    - Ovarian
    - Leukemia

The report includes statistical information for cancers by type
worldwide, with special emphasis on the U.S. market. Specifically, cancers
where there is current vaccines development are profiled. Each market segment
provides an overview, descriptions of products available or in development,
market estimates and forecasts for 2010-2015, and competitive analysis of
leading developers for 2015.

The report also includes current issues and trends affecting the
industry.

This area of medicine is a new frontier and many of the issues that face
the cancer vaccine market are novel. However, this is a very promising area
of medicine, which will continue to assist in the fight against cancer.

Issues and trends discussed in The Emerging Cancer Vaccine Market
include:

    - Early Detection and Screening
    - Monoclonal Antibodies and Therapeutic Vaccines
    - Safety Concerns
    - Insurance and Reimbursement Issues
    - Personalized Medicine
    - Pharmacogenomics
    - Vaccine Strategies
    - Economic Conditions and Vaccine Discovery

The information for this report was gathered using both primary and
secondary research including comprehensive research of secondary sources such
as company literature, databases, investment reports, and medical and
business journals. Telephone interviews and email correspondence were the
primary method of gathering information.

For the purpose of this study Kalorama Information conducted interviews
with key industry officials, consultants, health care providers, and
government personnel. These sources were the primary basis in gathering
information specifically relating to revenue and market share data presented
in this report. Specific interviews with pharmaceutical company
representatives included marketing directors, division managers, and
development representatives.

All market data pertains to the world market at the manufacturers' level.
The years outlined in this study include projected markets for 2010 thru
2015. Compound annual growth rates (CAGRs) are provided for the 2010-2015 for
each vaccine segment covered. Competitive analysis is provided for the year
2015 for the developing and emerging market. The projected competitive
analysis for 2015 was based on products in late stage development,
probability of approval and marketing, and demographic trends.

Several companies have promising research and development activities for
cancer vaccines. Additionally, many companies are in early stage development
with a focused effort on providing favorable results in treating cancer. Many
of these companies are:

    - Accentia
    - Antigenics
    - AVAX
    - Dendreon
    - GlaxoSmithKline
    - Merck & Co.
    - Northwest Biotherapeutics
    - Oncothyreon
    - Vaccinogen

Browse all Healthcare Reports at
www.reportsandreports.com/market-research/healthcare/

Browse All Specific Markets:
www.reportsandreports.com/tagIndex.aspx

Browse All Latest Reports:
www.reportsandreports.com/LatestReport.aspx

Browse All Cancer Vaccine Reports:
www.reportsandreports.com/tags/cancer-vaccines-market-research.html

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth
market research studies of over 5000 micro markets, and 25 industry specific
websites. Our client list boasts almost all well-known publishers of such
reports across the globe. We as a third-party reseller of market research
reports employ a number of marketing tools, such as press releases,
email-marketing and effective search-engine optimization techniques to drive
revenues for our clients. We also provide 24/7 online and offline support
service to our customers.

(Due to the length of these URLs, it may be necessary to copy and paste
the hyperlinks into your Internet browser's URL address field. Remove the
space if one exists.)

    Contact:

    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004

    reportsandreports.blogspot.com/
    reportsandreports.proarticles.co.uk/
    reportsnreports.wordpress.com/

Ms. Sunita, 7557 Rambler road, Suite 727, Dallas, TX 75231, Tel: +1-888-989-8004